Veterinary Ultrasound Market Worth $520.11 Million by 2030 - Exclusive Report by Meticulous Research®
February 06, 2023 10:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Veterinary Ultrasound Market by Animal Type [Small, Large (Equine, Farm)], Scanner [Cart-based,...
Ashvattha Therapeutics Announces First Patient Enrolled in a Phase 1 Study of [18F]OP-801 for Use as Imaging Agent
February 06, 2023 08:30 ET
|
Ashvattha Therapeutics
– The study will evaluate the safety, tolerability and ability of [18F]OP-801 to cross the blood brain barrier and selectively target neuroinflammation in individuals with ALS and healthy volunteers –...
Endogena Therapeutics Receives US FDA Fast Track Designation for EA-2353 for the Treatment of Retinitis Pigmentosa
February 06, 2023 07:00 ET
|
Endogena
SAN FRANCISCO, TORONTO and ZÜRICH, Switzerland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a clinical-stage biotech company focused on the development of endogenous...
iTrace Version 7.0 Releases with New Dry Eye and Quality of Vision Assessment Tools
February 02, 2023 17:06 ET
|
Tracey Technologies
Houston, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Houston, Texas - Houston, TX — Tracey Technologies announced the release of the 7th generation of software, called “iTrace Prime,” adding several...
Frontera Therapeutics Doses First Patient in a Clinical Trial of FT-003 Gene Therapy for the Treatment of Wet AMD
February 02, 2023 09:00 ET
|
Frontera Therapeutics
BEDFORD, Mass. and SHANGHAI, China, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Frontera Therapeutics, a global clinical-stage biotechnology company that seeks to develop novel and best-in-class gene therapy...
Ashvattha Therapeutics to Present at Upcoming Investor Conferences
February 02, 2023 08:30 ET
|
Ashvattha Therapeutics
REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company leveraging its nanomedicine technology, hydroxyl dendrimers (HDs), to develop a...
Standard Optical LASIK Surgeon Dr. Spencer Celebrates One-Year Anniversary
January 31, 2023 12:26 ET
|
Standard Optical - West Valley Eye Doctor
Salt Lake City, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Salt Lake City, Utah - Salt Lake City, UT – Standard Optical is excited to celebrate LASIK and cataract surgeon Dr. Terrence Spencer’s one-year...
LUMIBIRD: FY 2022 REVENUES OF €191M (+18%)
January 30, 2023 11:45 ET
|
Lumibird SA
Lannion, 30 March 2023 – 17:45 LUMIBIRD: FY 2022 REVENUES OF €191M (+18%) Accelerated growth for both divisions during challenging global timesNew record in Q4 with revenues of €66m (+32%)EBITDA...
Ophthalmology Drugs Global Market Opportunities And Strategies To 2031
January 30, 2023 08:07 ET
|
ReportLinker
New York, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ophthalmology Drugs Global Market Opportunities And Strategies To 2031" -...
Dell Laser Consultants Announces Treatment of First Patient in Austin With the IC-8® Apthera™ IOL
January 27, 2023 16:00 ET
|
Dell Laser Consultants
AUSTIN, Texas, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Dr. Steven J. Dell at Dell Laser Consultants is the first in Austin, Texas, to treat cataract patients with the IC-8® Apthera™ IOL since its U.S. FDA...